SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - GAMIDA CELL LTD ownership

GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 59 filers reported holding GAMIDA CELL LTD in Q2 2022. The put-call ratio across all filers is 3.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of GAMIDA CELL LTD
ValueSharesWeighting
Q1 2022$530,000
+55.0%
127,595
-5.1%
0.01%
+11.1%
Q4 2021$342,000
-38.7%
134,462
-5.5%
0.01%
-10.0%
Q3 2021$558,000
+541.4%
142,295
+1229.9%
0.01%
+900.0%
Q1 2021$87,000
-3.3%
10,7000.0%0.00%
-50.0%
Q4 2020$90,000
+104.5%
10,7000.0%0.00%
+100.0%
Q3 2020$44,000
-10.2%
10,7000.0%0.00%
-50.0%
Q2 2020$49,00010,7000.00%
Other shareholders
GAMIDA CELL LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,318,207$26,844,0002.86%
Stonepine Capital Management, LLC 244,515$1,978,0001.07%
Healthcare Value Capital, LLC 50,000$405,0000.90%
Rock Springs Capital Management LP 2,100,300$16,991,0000.37%
Dorsey Wright & Associates 3,619$29,278,0000.34%
FIRST MIDWEST BANK TRUST DIVISION 302,487$2,447,0000.34%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 107,000$862,0000.23%
Guild Investment Management, Inc. 15,000$121,0000.13%
PREMIER ASSET MANAGEMENT LLC 86,464$699,0000.12%
DRIEHAUS CAPITAL MANAGEMENT LLC 973,575$7,876,0000.12%
View complete list of GAMIDA CELL LTD shareholders